76 related articles for article (PubMed ID: 24276189)
1. [Involvement of matrix metalloproteinases in acute coronary syndrome (ACS)].
Pérez-Hernández N; Ibanes-Gutiérrez C; Vargas-Alarcón G; Martínez-Rodríguez N; Monroy-Muñoz IE; Valente-Acosta B; Pérez-Méndez O; Barrera-Ramírez R; Juárez-Cedillo T; Rodríguez Pérez JM
Gac Med Mex; 2013; 149(6):655-67. PubMed ID: 24276189
[TBL] [Abstract][Full Text] [Related]
2. Matrix metalloproteinases in coronary artery disease.
Mittal B; Mishra A; Srivastava A; Kumar S; Garg N
Adv Clin Chem; 2014; 64():1-72. PubMed ID: 24938016
[TBL] [Abstract][Full Text] [Related]
3. Role of matrix metalloproteinases in coronary artery disease.
Shah VK; Shalia KK; Mashru MR; Soneji SL; Abraham A; Kudalkar KV; Vasvani JB; Sanghavi ST
Indian Heart J; 2009; 61(1):44-50. PubMed ID: 19729688
[TBL] [Abstract][Full Text] [Related]
4. [Acute coronary syndrome-initiating factors].
Tsujita K; Kaikita K; Soejima H; Sugiyama S; Ogawa H
Nihon Rinsho; 2010 Apr; 68(4):607-14. PubMed ID: 20387549
[TBL] [Abstract][Full Text] [Related]
5. The clinical implications of increased OX40 ligand expression in patients with acute coronary syndrome.
Liu DM; Yan JC; Wang CP; Chen GH; Ding S; Liu PJ; Du RZ
Clin Chim Acta; 2008 Nov; 397(1-2):22-6. PubMed ID: 18674525
[TBL] [Abstract][Full Text] [Related]
6. A common polymorphism in CD40 Kozak sequence (-1C/T) is associated with acute coronary syndrome.
Tian C; Qin W; Li L; Zheng W; Qiu F
Biomed Pharmacother; 2010 Mar; 64(3):191-4. PubMed ID: 20137882
[TBL] [Abstract][Full Text] [Related]
7. [Definition and pathophysiology of acute coronary syndrome].
Fujimoto H; Yamaguchi T
Nihon Rinsho; 2006 Apr; 64(4):611-6. PubMed ID: 16613176
[TBL] [Abstract][Full Text] [Related]
8. Matrix metalloproteinases in acute coronary syndromes: a new therapeutic target?
Celik T; Iyisoy A; Kardesoglu E; Bugan B; Isik E
Int J Cardiol; 2009 May; 134(3):402-4. PubMed ID: 18237788
[TBL] [Abstract][Full Text] [Related]
9. The T29C polymorphism of the transforming growth factor-β1 (TGF-β1) gene is associated with genetic susceptibility to acute coronary syndrome in Mexican patients.
Fragoso JM; Martínez-Ríos MA; Alvarez-León E; Vallejo M; Peña-Duque MA; Posadas-Sánchez R; Posadas-Romero C; Furuzawa-Carballeda J; Lima G; Llorente L; Vargas-Alarcón G
Cytokine; 2012 Jun; 58(3):380-3. PubMed ID: 22465044
[TBL] [Abstract][Full Text] [Related]
10. Smoking and Unstable Plaque in Acute Coronary Syndrome: A Systematic Review of The Role of Matrix Metalloproteinases.
Aminuddin A; Cheong SS; Roos NAC; Ugusman A
Int J Med Sci; 2023; 20(4):482-492. PubMed ID: 37057211
[TBL] [Abstract][Full Text] [Related]
11. [Association of matrix metalloproteinase-9 and platelet membrane glycoprotein VI polymorphisms with acute coronary syndrome].
Qin Q; Zhao BR; Mao YM; Cui RZ; Kou L; Li YL; Zhao FM; Hui RT
Zhonghua Xin Xue Guan Bing Za Zhi; 2005 Jul; 33(7):622-6. PubMed ID: 16080811
[TBL] [Abstract][Full Text] [Related]
12. Platelets release matrix metalloproteinase-2 in the coronary circulation of patients with acute coronary syndromes: possible role in sustained platelet activation.
Gresele P; Falcinelli E; Loffredo F; Cimmino G; Corazzi T; Forte L; Guglielmini G; Momi S; Golino P
Eur Heart J; 2011 Feb; 32(3):316-25. PubMed ID: 21036774
[TBL] [Abstract][Full Text] [Related]
13. The pathophysiology of coronary artery aneurysms in Kawasaki disease: role of matrix metalloproteinases.
Senzaki H
Arch Dis Child; 2006 Oct; 91(10):847-51. PubMed ID: 16990356
[TBL] [Abstract][Full Text] [Related]
14. Elevated circulating levels of matrix metalloproteinase-9 and -2 in patients with symptomatic coronary artery disease.
Zeng B; Prasan A; Fung KC; Solanki V; Bruce D; Freedman SB; Brieger D
Intern Med J; 2005 Jun; 35(6):331-5. PubMed ID: 15892761
[TBL] [Abstract][Full Text] [Related]
15. The MHC2TA 1614 C>G gene polymorphism is associated with risk of developing acute coronary syndrome.
Vargas-Alarcón G; Martínez-Ríos MA; Peña-Duque MA; Posadas-Romero C; Cardoso-Saldaña G; Vallejo M; Ramírez-Bello J; Pérez-Méndez O; Fragoso JM
Mol Immunol; 2013 Oct; 55(3-4):424-8. PubMed ID: 23511026
[TBL] [Abstract][Full Text] [Related]
16. Matrix metalloproteinases: influence on smooth muscle cells and atherosclerotic plaque stability.
Johnson JL
Expert Rev Cardiovasc Ther; 2007 Mar; 5(2):265-82. PubMed ID: 17338671
[TBL] [Abstract][Full Text] [Related]
17. [Structure and function of matrix metalloproteinases].
Olszyński K; Zimowska M
Postepy Biochem; 2009; 55(1):76-84. PubMed ID: 19514468
[TBL] [Abstract][Full Text] [Related]
18. Plasma level of growth arrest-specific 6 (GAS6) protein and genetic variations in the GAS6 gene in patients with acute coronary syndrome.
Jiang L; Liu CY; Yang QF; Wang P; Zhang W
Am J Clin Pathol; 2009 May; 131(5):738-43. PubMed ID: 19369636
[TBL] [Abstract][Full Text] [Related]
19. Dual role of matrix metalloproteinases (matrixins) in intimal thickening and atherosclerotic plaque rupture.
Newby AC
Physiol Rev; 2005 Jan; 85(1):1-31. PubMed ID: 15618476
[TBL] [Abstract][Full Text] [Related]
20. [Inflammatory biomarker for diagnosis of coronary diseases].
Soejima H; Kishikawa H; Ogawa H
Nihon Rinsho; 2011 Jan; 69(1):74-8. PubMed ID: 21226264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
